Skip to content

Home Bicycle Exercise and Aerobic Capacity

The Effects of Home Bicycle Exercise Program on Hyperlipidemia, Hypertension, Blood Sugar Control, Muscle Strength and Aerobic Capacity

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02268292
Enrollment
37
Registered
2014-10-20
Start date
2012-08-31
Completion date
2014-08-31
Last updated
2014-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Cardiovascular Syndrome

Keywords

Metabolic syndrome, Diabetes, Muscle strength, Aerobic exercise, Bicycle, Brain-derived neurotrophic factor

Brief summary

The subjects with MetS or type 2 diabetes were enrolled for this exercise-training program. All participators underwent an indoor bicycle exercise for twelve weeks. In addition to demographic data and biochemical tests were determined after an overnight fasting. Extension of muscle strength was detected in the dominant lower extremity.

Detailed description

This prospective open-labeled study was conducted in Taichung Veterans General Hospital. The adult participants with metabolic syndrome and/or type 2 diabetes were enrolled. MetS. The procedures were fully explained to all subjects before the cardiopulmonary exercise test. ll enrolled subjects received a scheduled twelve-week program for exercise-training program. A commercially available bicycle with an indoor bicycle trainer are used as the home exercise training modality. All medications were not allowed to be changed during the study.

Interventions

All enrolled subjects received a scheduled twelve-week exercise program. A commercially available bicycle (Giant CS800, Taichung, Taiwan) with an indoor bicycle stand (Giant Cyclotron Mag, Taichung, Taiwan) was used as the home exercise training modality.

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Adult with metabolic syndrome or type 2 diabetes

Exclusion criteria

* hyperglycemic crisis or HbA1c \> 12%; * serum creatinine levels greater than 200 mmol/L; * acute or chronic infectious diseases; * limitations in the ability to undertake regular exercise

Design outcomes

Primary

MeasureTime frameDescription
Metabolic syndrome12 weeksComponents of metabolic syndrome based on the modified Third Report of the National Cholesterol Education Program (NCEP) criteria

Secondary

MeasureTime frameDescription
Muscle strength12 weeksA Biodex Isokinetic Dynamometer (Biodex Medical Systems, Inc., Shirley, New York, USA) was used to evaluate the muscle strength of the subjects
Brain-derived neurotrophic factor12 weeksSerum concentration of Brain-derived neurotrophic factor (enzyme immunoassay method, R&D Systems, Minneapolis, U.S.A.)
Arterial stiffness12 weeksPulse wave velocity

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026